Summary by Moomoo AI
Universe Pharmaceuticals announced the appointment of Enrome LLP as its new independent registered public accounting firm effective October 8, 2024, replacing YCM CPA INC. The change was approved by the company's audit committee after careful consideration and evaluation.The company emphasized that the auditor change was not due to any disagreements on accounting principles, financial statement disclosure, or auditing procedures. YCM's audit reports for fiscal years 2022 and 2023 contained no adverse opinions or modifications. The only notable issue was previously reported material weaknesses under Item 15 of the company's annual report for fiscal year 2023.Prior to Enrome's engagement, there were no consultations regarding specific transactions, audit opinions, or financial reporting matters between the firm and Universe Pharmaceuticals. The company has provided YCM with the disclosure and requested their confirmation letter to the SEC.
